You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 30, 2026

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
Y Yang1, X Ren, H J Schluesener
1Experimental Medicine Center of Tongji Hospital, Wuhan 430030, People's Republic of China.
Aptamers, generated via SELEX, offer high-affinity binding for biomedical applications. Recent modifications enhance their stability and bioavailability, advancing aptamer use in diagnosing and treating nervous system disorders.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: